Bio-Rad Laboratories Inc. (NYSE: BIO): Jefferies maintained a Buy rating with a $615 target price. The consensus target is $616.80. The shares closed on Thursday at $492.13.
CymaBay Therapeutics Inc. (NASDAQ: CBAY): BTIG Research started coverage with a Buy rating and a $15 target price. The consensus target is $12. The shares closed on Thursday at $9.02.
Etsy Inc. (NYSE: ETSY): Jefferies downgraded the stock to Underperform from Buy. It also chopped its $150 target price to $85, well below the $139.31 consensus target. The shares closed almost 5% lower on Thursday at $107.85 after the double downgrade.
Exact Sciences Corp. (NASDAQ: EXAS): Citigroup lifted its Neutral rating to Buy, and the $70 target price increased to $90. The consensus target is $73.65. The shares closed on Thursday at $66.18.
Fortune Brands Innovations Inc. (NYSE: FBIN): Credit Suisse downgraded the shares to Underperform from Neutral and has a $48 target price. The consensus target is $68.07. Thursday’s final trade was reported at $60.65.
Guardant Health Inc. (NASDAQ: GH): Citigroup’s downgrade from Buy to Neutral included a target price cut from $60 all the way to $33. The consensus target is $57.63. Thursday’s $27.67 close was down over 4% for the day on the downgrade.
Hilton Worldwide Holdings Inc. (NYSE: HLT): Barclays upgraded the stock to Overweight from Equal Weight. It also boosted its $151 target price to $168, while the consensus target is $148.18. The last trade on Thursday was reported at $145.38.
Hyatt Hotels Corp. (NYSE: H): Barclays downgraded the shares to Equal Weight from Overweight and trimmed its $130 target price to $125. The consensus target is $123.16. The stock ended Thursday trading at $114.63.
Life Time Group Holdings Inc. (NYSE: LTH): Oppenheimer reiterated an Outperform rating and has a $33 target price. The consensus target is just $19.70. The stock closed on Thursday at $17.45.
Meta Platforms Inc. (NASDAQ: META): Oppenheimer reiterated an Outperform rating on the Facebook and Instagram parent and raised its $220 target price to $235. The consensus target is $208.74. Thursday’s close was at $181.36.
MongoDB Inc. (NASDAQ: MDB): Goldman Sachs lowered its $325 price target to $280 but maintained a Buy rating. The consensus target is $258.66 for now. The shares closed on Thursday at $207.73, down almost 10% on the day despite a fourth-quarter earnings beat.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
